Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001610520-24-000160·Amneal Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Amneal Pharmaceuticals Inc
Class A Common Stock, par value $0.01 per share · CUSIP: 03168L105
Event date: 2024-09-30
- Filing-level shares
- 21,491,881.00
- Percent of class
- 6.9%
- UBS Group AG
Shares: 21,491,881.00 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001610520-24-000160
- Form type
- SCHEDULE 13G
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Oct 30, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership